- Home
- CNH vs NBIX Comparison
CNH vs NBIX Comparison
Compare CNH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNH
- NBIX
- Stock Information
- Founded
- CNH 1842
- NBIX 1992
- Country
- CNH United Kingdom
- NBIX United States
- Employees
- CNH N/A
- NBIX N/A
- Industry
- CNH Construction/Ag Equipment/Trucks
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNH Industrials
- NBIX Health Care
- Exchange
- CNH Nasdaq
- NBIX Nasdaq
- Market Cap
- CNH 12.6B
- NBIX 14.4B
- IPO Year
- CNH N/A
- NBIX 1996
- Fundamental
- Price
- CNH $9.94
- NBIX $147.21
- Analyst Decision
- CNH Buy
- NBIX Strong Buy
- Analyst Count
- CNH 12
- NBIX 18
- Target Price
- CNH $13.67
- NBIX $172.33
- AVG Volume (30 Days)
- CNH 13.5M
- NBIX 1.1M
- Earning Date
- CNH 11-07-2025
- NBIX 10-28-2025
- Dividend Yield
- CNH 2.52%
- NBIX N/A
- EPS Growth
- CNH N/A
- NBIX 12.44
- EPS
- CNH 0.48
- NBIX 4.19
- Revenue
- CNH $17,814,000,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- CNH N/A
- NBIX $23.68
- Revenue Next Year
- CNH $2.21
- NBIX $18.02
- P/E Ratio
- CNH $20.75
- NBIX $35.13
- Revenue Growth
- CNH N/A
- NBIX 19.61
- 52 Week Low
- CNH $9.00
- NBIX $84.23
- 52 Week High
- CNH $14.27
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- CNH 37.95
- NBIX 54.30
- Support Level
- CNH $9.00
- NBIX $133.62
- Resistance Level
- CNH $10.61
- NBIX $157.67
- Average True Range (ATR)
- CNH 0.32
- NBIX 5.20
- MACD
- CNH -0.06
- NBIX 0.58
- Stochastic Oscillator
- CNH 45.26
- NBIX 56.13
About CNH CNH Industrial N.V.
CNH Industrial is the world's second largest manufacturer of agricultural machinery (82% of industrial net sales) as well as a major player in construction equipment (18% of industrial net sales). Its Case and New Holland brands have served farmers for generations. Geographically, agriculture sales are 40% North America, 32% Europe, Middle East, and Africa, 18% South America, and 10% Asia-Pacific. CNH's products are available through a robust independent dealer network, which includes over 2,600 dealer and distribution locations and reach into 164 countries. The construction business leverages over 400 dealers. The company's captive finance arm provides retail financing to its customers as well as wholesale financing for dealers to maintain inventory, which supports sales.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.